Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip
about
Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseasesOverview of protein microarraysFunctional protein microarray as molecular decathlete: a versatile player in clinical proteomicsHost genetics and environmental factors regulate ecological succession of the mouse colon tissue-associated microbiotaIdentification of bacterial factors involved in type 1 fimbria expression using an Escherichia coli K12 proteome chipProteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead.Identification of lactoferricin B intracellular targets using an Escherichia coli proteome chip.Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease.Antibody profiling of bipolar disorder using Escherichia coli proteome microarraysProfiling the humoral immune response of acute and chronic Q fever by protein microarray.Lactoferricin B inhibits the phosphorylation of the two-component system response regulators BasR and CreB.Serum Proteome Profiles in Stricturing Crohn's Disease: A Pilot Study.Mining gut microbiome oligopeptides by functional metaproteome display.Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approachIdentification of new autoantigens for primary biliary cirrhosis using human proteome microarrays.Applications of functional protein microarrays in basic and clinical research.Systematic Analysis of Intracellular-targeting Antimicrobial Peptides, Bactenecin 7, Hybrid of Pleurocidin and Dermaseptin, Proline-Arginine-rich Peptide, and Lactoferricin B, by Using Escherichia coli Proteome MicroarraysDissecting protein function and signaling using protein microarrays.Interactome mapping: using protein microarray technology to reconstruct diverse protein networks.Noninvasive methods in evaluation of inflammatory bowel disease: where do we stand now? An update.Protein-protein interactions and selection: array-based techniques for screening disease-associated biomarkers in predictive/early diagnosis.Functional protein microarray technology.Proteomics at the interface of psychology, gut physiology and dysfunction: an underexploited approach that deserves expansion.Current advantages in the application of proteomics in inflammatory bowel disease.Serum proteomics in biomedical research: a systematic review.High throughput platform to explore RNA-protein interactomes.Characterization of protein-DNA interactions using protein microarrays.Advances in the development of human protein microarrays.PTMA, a new identified autoantigen for oral submucous fibrosis, regulates oral submucous fibroblast proliferation and extracellular matrix.Antigen Analysis of Pre-Eclamptic Plasma Antibodies Using Escherichia Coli Proteome Chips.Antibody Profiling of Kawasaki Disease Using Escherichia coli Proteome Microarrays.An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients
P2860
Q21090656-0477827C-BA7D-4E10-94A8-A76E49D6FD4FQ26830244-32A89929-E0B1-46F7-98D0-821B763DBC16Q27025953-959E10D4-A848-47E0-B0FE-A17FD63D1E0FQ28732754-CF343B51-C5E8-436F-B749-A4E38D6C7852Q33718716-B3AD4A4B-8578-4883-8DC0-67AE24FE4688Q33891197-17FE0F18-C1D2-40F9-88C9-A4D3752406FCQ34099056-8E77B506-FECD-4040-9D30-8E3742A92875Q34241773-488C480F-EA19-44FE-B1AF-47F39C858134Q35148349-10A612DD-BE1E-4354-9715-7F77232C0480Q35497361-1DCEAB82-3030-446A-9CCC-F621E4FE7F1EQ35878781-774F126E-9F27-45E9-8805-031B86A5B2D3Q35880979-C5527745-B993-480E-8CDC-DF6D076D9493Q36153085-88724DE7-0CAD-488B-A859-FF0B68608836Q36211543-27279FC7-C92C-4FA6-A179-A30204C4401FQ36211824-CFE33EBC-12A6-4D3B-8814-B6FFC1E5BE89Q37214216-CDA9055A-E5D3-463E-A426-BDD6BDFE713BQ37372278-2B2444E0-9F82-4754-8DF4-7787F08AC4AEQ37574617-5A281529-B8BC-49F5-968C-AA6FD5315602Q37671058-CE89A0EE-4521-406C-904D-F800BC625267Q37698973-7D682B9D-EA2B-4992-BEA1-9BD191B2C896Q37735872-59EC6A3F-11B8-43C5-B3F0-1AB22C2D6C94Q37792975-EBF05600-D51B-4478-BD00-102E7FFDC55BQ37945789-CA2F2536-642C-4B95-89F9-1F5D49D68AF2Q38022190-5F3B8D07-BDA6-46A0-A8A6-83BDD96C5F7BQ38101008-A18488B9-5523-4D6A-8EB7-ADE7C8B8D971Q38229626-57343A9D-DD9D-437E-8725-270B252A46A3Q38335472-F5F6A5FB-1FC4-472C-B667-F6EACB1D09DAQ39394355-8B3EAE4C-557F-498E-9E85-4F4BB9B84210Q43170928-3E0D62F0-4F00-406F-B9EF-FF15693399DEQ47248937-6018DF25-AC40-4A18-A86D-E2FC031EA9F0Q47287596-3D48F24C-1FFE-4192-96F1-8B6C5E134D19Q58580473-F9DEB569-CAF6-4848-BF33-EC593787B8CE
P2860
Identification of novel serological biomarkers for inflammatory bowel disease using Escherichia coli proteome chip
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of novel serolo ...... Escherichia coli proteome chip
@en
Identification of novel serolo ...... scherichia coli proteome chip.
@nl
type
label
Identification of novel serolo ...... Escherichia coli proteome chip
@en
Identification of novel serolo ...... scherichia coli proteome chip.
@nl
prefLabel
Identification of novel serolo ...... Escherichia coli proteome chip
@en
Identification of novel serolo ...... scherichia coli proteome chip.
@nl
P2093
P2860
P921
P1476
Identification of novel serolo ...... Escherichia coli proteome chip
@en
P2093
Aik Choon Tan
C Lynne Burek
Carmen Cuffari
Chien-Sheng Chen
Lisa Wu Datta
Monica V Talor
Philip J Alex
Raimond L Winslow
P2860
P304
P356
10.1074/MCP.M800593-MCP200
P577
2009-04-07T00:00:00Z